Cyclopharm Limited (ASX: CYC)
Health Care · Health Care Equipment & Supplies · AU
AU$0.50
-3.88% today · -49.5% 1Y
Cyclopharm Limited (ASX: CYC) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $44.73M and employs 109 people.
Over the last twelve months the share price has lost 49.5%, trading between 0.45 and 1.29.
Tweenvest scores Cyclopharm Limited across four factors: quality 39/100, value 56/100, growth 69/100. Its strongest factor is growth.
CYC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $44.73M
- Revenue (TTM)
- $21.56M
- P/E
- —
- EPS
- -0.16
- Dividend yield
- —
- Beta (5Y)
- 0.59
- 52-week high
- AU$1.29
- 52-week low
- AU$0.45
- Avg volume (3M)
- —
- Shares outstanding
- 126.07M
- Employees
- 109
- Next earnings
- —
About Cyclopharm Limited
Cyclopharm Limited is an international enterprise specializing in the production and global distribution of medical devices and radiopharmaceuticals, with operations spanning Asia Pacific, Europe, Canada, and other regions. The company's business activities are structured into two principal divisions: Technegas and Molecular Imaging. Through its Technegas segment, Cyclopharm supplies diagnostic apparatus and accompanying consumables critical for clinicians in the identification of pulmonary embolisms, alongside distributing third-party offerings to the broader diagnostic imaging sector. Conversely, the Molecular Imaging division provides advanced radiopharmaceutical agents essential for medical practitioners diagnosing conditions such as cancer, various neurological disorders, and cardiac diseases. Cyclopharm primarily serves nuclear medicine departments. Established in 1986, the company's corporate headquarters are located in Kingsgrove, Australia.
- ISIN
- AU000000CYC5
- Founded
- 1986
- Listed since
- Jan 17, 2007
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $114.10 | -1.75% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $371.78 | -0.02% |
| Stryker CorporationNYSE: SYK | $126.81B | $329.67 | -0.28% |
| Medtronic plcNYSE: MDT | $116.66B | $92.02 | +0.97% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €159.20 | +0.03% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $48.17 | -3.39% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.78 | -0.10% |
Figures last refreshed Aug 18, 2026.